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ABSTRACT 
 
Melissa B.Behr 
The Cytokine Response to Three Days of Intensive Training 
(Under the direction of Anthony C. Hackney, Ph.D.) 
 
This experiment determined the acute and cumulative responses of IL-6 and TNF-7 to 
three consecutive days of intensive training (Session I, II and III).  Results showed that 
exercise caused a similar increase in IL-6 from pre- to post-exercise for all sessions, but no 
changes in resting, baseline values. Results also showed an increase in TNF-7 after Sessions 
II and III, but not Session I.  The percent change in TNF-7 was greatest for Session II, and 
resting TNF-7 was significantly elevated by the end of the study.  In conclusion, three days 
of intensive training separated by ~24 hours do not result in a significant widening of the 
“Open Window” period following exercise, as the environment created by exercise in 
predominantly anti-inflammatory, as evidenced by increased IL-6. This means that athletes 
who train intensively for three consecutive days do not appear to be at a greater risk of 
becoming ill. 
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CHAPTER I 
 
Introduction 
 
Following an injury or an infection, there is a complex sequence of cellular and 
humoral responses aimed at limiting tissue damage and activating the repair process, 
collectively known as inflammation.35 The inflammatory process begins with an initial phase 
of acute neutrophil accumulation, followed by mononuclear cell accumulation, and ends with 
a resolution phase, in which repair of injured tissue is completed.5, 35 Inflammatory reactions 
that are acute in nature usually run a definite and limited time course; however, if the 
injurious stimulus is repeatedly applied, as may occur with sports training, chronic 
inflammation may develop.35 
In both acute and chronic inflammation, there is an up-regulation of cytokines.20, 25, 35 
Cytokines are soluble glycoproteins, usually between 8-30 kilodaltons (kDa) in mass, which 
are produced by, and mediate communication between and within immune and non-immune 
cells, organs, and organ systems throughout the body.10, 16, 17, 18, 21, 22 Cytokines can be 
functionally divided into two groups: pro-inflammatory cytokines and anti-inflammatory 
cytokines.25 Pro-inflammatory cytokines are up-regulated by physical activity, trauma, 
autoimmune diseases, infection and certain types of cancer.18, 20, 35 Pro-inflammatory 
cytokines are important in the initiation and progression of the inflammatory process.21, 35 
Two major pro-inflammatory cytokines are Tumor Necrosis Factor-alpha (TNF-7) and 
Interleukin-6 (IL-6).20, 25, 28, 35 Conversely, anti-inflammatory cytokines serve to attenuate the 
2inflammatory network once the inflammatory process has begun.19, 21, 35 Anti-inflammatory 
cytokines include Tumor Necrosis Factor-Receptor (TNF-R), Interleukin 1-receptor agonist 
(IL-1ra) and Interleukin10 (IL-10).20, 21, 25, 28, 35 IL-6 has also been shown to have aspects of 
an anti-inflammatory cytokine.  It may have immune regulatory effects by inhibiting TNF-
7,14, 26, 39 a major pro-inflammatory cytokine. It also induces upregulation of IL-1ra, a major 
anti-inflammatory cytokine.20, 39 Figure 1 illustrates the proposed interrelationship of the 
major pro- and anti-inflammatory cytokines.  
Figure 1. The cytokine cascade.  Pro-inflammatory cytokines, TNF-7 and IL-1 are released at 
the start of inflammation. Anti-inflammatory cytokines, TNF-R, IL1-ra and IL-10, 
attenuate the cascade once the inflammatory process has begun.20, 21, 25, 28, 35 IL-6 has been 
shown to have aspects of both a pro- and anti-inflammatory cytokine.16 
(Adapted from Pedersen, 2005) 
 
Regular, moderate intensity exercise has been shown to offer protection against all-
cause mortality 28, 32, 44, 47; however, athletes engaged in intensive exercise have demonstrated 
an increased susceptibility to infectious illnesses, such as upper respiratory tract infections, as 
well as infections of the eye, ear and skin.10, 12, 29, 30, 32, 35, 39, 44, 47 The increase in susceptibility 
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3has been associated with the overtraining syndrome (OTS), or decrements, rather than 
improvements, in exercise performance that occur with frequent, intense training.30,35, 36 The 
OTS is associated with suppressed immune function.12 Pro-inflammatory cytokines are 
released into the circulatory system in response to intensive exercise, causing inflammation.24 
The immune system is then occupied with the task of responding to that inflammation.  
Researchers have suggested a cytokine “Open Window” (see Figure 2A) that occurs in the 
time period between three and 72 hours after exercise.22, 35 During this time, pathogens, such 
as viruses and bacteria, may gain a “foothold” in the body, because the immune system 
cannot adequately respond to both the inflammation caused by the intensive exercise and the 
pathogen, thus increasing the risk of infection.22, 35 
Figure 2. (A) The cytokine Open Window.  This window occurs 3-72 hours post-exercise, 
and is a period of time in which athletes are more susceptible to illness. (B) Cumulative 
effects of the cytokine Open Window.  These effects may result in chronically altered 
immune function.22, 35 
Several researchers have investigated the IL-6 response to exercise.  Studies have 
shown an increase in IL-6 immediately after acute bouts of prolonged exercise ranging from 
one hour to six hours in duration (see Table 1).5, 9, 10, 17, 20, 21, 24, 45 In the case of TNF-7,
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4participants who perform an acute bout of aerobic exercise, two hours or more in duration, 
demonstrate an increased circulation of TNF-7 immediately post-exercise 5, 7, 9, 10, 17, 21, 45;
whereas participants who perform an acute bout of aerobic exercise less than two hours in 
duration do not demonstrate a change in circulating TNF-7 immediately post-exercise (see 
Table 1).10, 45 
Table 1. The IL-6 and TNF-7 responses to exercise. These studies will be discussed in detail 
in the review of literature. 
Cytokine Author Time 
(hr) 
Intensity 
(%VO2max)
Circulating 
Concentration 
Ullum et al.45 1 75% O
Haahr et al.10 1 75% O
Brenner et al.5 2 60% O
Nieman et al.21 2.5 74% O
Nehlsen-Cannarella et al.20 2.5 77% O
Moldoveanu et al.17 3 60-65% O
Ostrowski et al.24 ~3.5 “Competitive” O
IL-6 
Gannon et. al.9 6 “Competitive” O
Ullum et al.45 1 75% P
Haahr et al.10 1 75% P
Brenner et al.5 2 60% O
Dufaux & Order 7 2.5 “Competitive” O
Moldoveanu et al.17 3 60-65% O
Ostrowski et al.24 ~3.5 “Competitive” O
TNF-7
Gannon et. al.9 6 “Competitive” O
The results of these investigations indicate that individuals who perform an acute bout 
of prolonged exercise may increase their susceptibility to infection in the post-exercise 
recovery period due to the up regulation of pro-inflammatory cytokines, and the subsequent 
inflammation.  It is well known; however, that an athlete who is seriously training does not 
perform only a single, acute bout of exercise before taking a day to rest.  It is more likely that 
an endurance athlete performs cycles consisting of several consecutive days of intensive 
training before a rest day, also known as a micro-cycle.1 Elaborating on the Open Window 
idea presented earlier, researchers have proposed that an athlete who trains excessively 
5without adequate rest may show a cumulative effect of the Open Window period (see Figure 
2B).22, 35 In this case, the injurious stimulus is repeatedly applied, potentially leading to a 
more chronic type of inflammation.  At this point, the cytokine response to consecutive 
intensive training days is unknown.  Thus, it is not certain if changes in cytokine 
concentrations are cumulative over the course of an intensive micro-cycle.  If pro-
inflammatory cytokine concentrations are cumulative, an aerobic endurance athlete may be 
more susceptible to infection upon completion of a training micro-cycle due to the 
developing inflammation, meaning more rest time may be required for the athlete to 
appropriately recover before beginning another cycle of training. If the athlete does not have 
adequate time for rest, chronic inflammation may develop, along with an increased risk for 
development of the OTS. 
Statement of the Problem
The purposes of this experiment were to determine the acute and cumulative 
responses of IL-6 and TNF-7 to the three days of intensive training (i.e. micro-cycle), and to 
determine if there were differences in baseline values of IL-6 and TNF-7 during three days of 
intensive training. 
Research Questions
1. What is the acute effect of intensive training on IL-6? 
2. What is the cumulative effect of intensive training on IL-6? 
3. Is there a significant difference in resting levels of IL-6 during three days of intensive 
training exercise? 
4. What is the acute effect of intensive training on TNF-7?
5. What is the cumulative effect of intensive training on TNF-7?
66. Is there a significant difference in resting levels of TNF-7 during three days of intensive 
training? 
Research Hypotheses
Hypothesis 1: Plasma IL-6 will be significantly increased from rest immediately post-
exercise for each bout of intensive training.  
Hypothesis 2: The change in IL-6 will be of a greater magnitude with each successive bout of 
intensive training. 
Hypothesis 3: The resting concentrations of plasma IL-6 will be significantly elevated 
following each successive day of intensive training, and the following rest day. 
Hypothesis 4: Plasma TNF-7 will be significantly increased from rest immediately post- 
exercise for each bout of intensive training.  
Hypothesis 5: The change in TNF-7 will be of a greater magnitude with each successive bout 
of intensive training. 
Hypothesis 6: The resting concentrations of plasma TNF-7 will be significantly elevated for 
each successive day of intensive training, and the following rest day. 
Definition of Terms
Inflammation – A complex sequence of cellular and humoral responses aimed at limiting 
tissue damage and activating the repair process.21, 35 The inflammatory process begins with 
an initial phase of acute fluid and neutrophil accumulation to the site of injury, followed by 
mononuclear cell accumulation, and ends with a resolution phase, in which repair of injured 
tissue is completed.21, 35 
Cytokine – A soluble glycoprotein, usually between 8-30 kDa in mass, which is produced by 
and mediates communication between and within immune and non-immune cells, organs and 
7organ systems throughout the body.10, 16, 17, 18, 21, 22 Cytokines can be functionally divided into 
two groups: pro-inflammatory and anti-inflammatory.18, 35 
Pro-Inflammatory Cytokine – Cytokines that are important in the initiation and progression 
of inflammation.  They are up-regulated by physical activity, trauma, autoimmune diseases, 
infection and certain types of cancer.18, 20, 35. Two major pro-inflammatory cytokines are 
Tumor Necrosis Factor-alpha (TNF-7) and, in some cases, Interleukin-6 (IL-6).20, 25, 28, 35  
Anti-Inflammatory Cytokine – Cytokines that are released with the main purpose of 
regulating the inflammatory network.20, 21, 25, 28, 35 Major anti-inflammatory cytokines include 
Tumor Necrosis Factor- Receptor (TNF-R), Interleukin 1- receptor agonist (IL-1ra) and 
Interleukin -10 (IL-10), 20, 21, 25, 28 and in some cases IL-6.14, 20, 26, 39 
Tumor Necrosis Factor-alpha (TNF-7) – A pro-inflammatory cytokine that is mainly a 
product of mononuclear phagocytes, but is also produced by T lymphocytes, Kupffer cells, 
neural cells, muscle cells and endothelial cells.16, 18, 27 TNF-7 increases vascular permeability 
and migration of leukocytes to sites of infection and inflammation.16, 18 TNF-7 also works in 
combination with IL-6 to induce the acute phase response and fever.16 
Interleukin-6 (IL-6) – IL-6 is one of the most potent mediators of the acute phase immune 
response, and so it has been classified as both a pro- and an anti-inflammatory cytokine.16 
It is a glycoprotein produced by T lymphocytes, natural killer cells, monocytes and non-
immune cells, such as smooth muscle, contracting skeletal muscle, chondrocytes, astrocytes 
and glial cells.16, 27 IL-6 activates B cell growth and differentiation into antibody forming 
plasma cells.16 It works with pro-inflammatory cytokines, such as TNF-7, to initiate the acute 
phase response and the synthesis of hepatic acute-phase proteins, such as C-reactive 
protein.25, 40 IL-6 has also been shown to have aspects of an anti-inflammatory cytokine, in 
8that it may have immune regulatory effects by inhibiting TNF-7,14, 26, 39 and inducing 
upregulation of IL-1ra, a major anti-inflammatory cytokine.20, 39 
Cytokine Open Window - The time period between three and 72 hours after exercise in which 
pathogens, such as viruses and bacteria, may gain a “foothold” in the body.22, 35 This may 
happen because the immune system cannot adequately respond to both the inflammation 
caused by the intensive exercise and the pathogen, thus increasing the risk of infection.22, 35 
Intensive Training Trials – Three identical training trials, separated by ~24 hours, consisting 
of intensive prolonged exercise.  
Intensive Prolonged Exercise - Exercise performed above 70% of maximal oxygen 
consumption for 60-120 minutes.4, 11 
Assumptions
1. The participants adhered to all pre-experiment guidelines as instructed by the 
investigators. 
2. The first resting, baseline blood sample that was taken before the first Intensive Training 
Trial was a valid, stable baseline. 
Limitations 
1. There was a small number of participants in this investigation, potentially leading to 
sampling error. 
2. A typical athletic diet of 60% carbohydrate, 25% fat and 15% protein was recommended 
for all participants, and this diet was monitored; however, the participants were left to 
follow these guidelines without the provision of meals by the investigators. 
3. The large degree of variability in the VO2 measured during the Intensive Training Trials 
could have affected the results obtained. 
9Delimitations
1. Only healthy, non-smoking, moderately trained males aged 18-45 were recruited for the 
investigation. 
2. Diet was not strictly controlled, but it was monitored.  The standards were based on an 
athletic population, and may not be applicable to those who are part of a non-athletic 
population. 
3. There was a 24 hour period between Intensive Training Trials in which post-exercise 
recovery blood samples were not obtained. 
4. One hour of exercise at 75% of VO2peak was chosen as the exercise duration and intensity 
of the study.
CHAPTER II 
 
Review of Literature 
 
This review of literature will be presented in the following format: It will begin with a 
brief overview of basic cytokine physiology related to exercise.  Following the overview, the 
IL-6 and TNF-7 responses to exercise will be discussed in detail.  For both the discussion of 
IL-6 and the discussion of TNF-7, the review will be organized based on duration of the 
exercise protocol.  Studies utilizing the shortest duration of exercise (60 minutes) will appear 
first, followed by studies of increasing exercise duration, and ending with studies utilizing 
the longest exercise duration (6 hours). The review of literature concludes with a summary 
statement. 
Cytokine Physiology
Exercise causes many alterations within the immune system.  Some of these changes 
include release of inflammatory mediators, activation of white blood cells and induction of 
acute phase proteins, which enhance the immune response to a pathogen.16, 22 Cytokines, as 
described earlier, are the inflammatory mediators.  They are molecules involved in 
communication between cells involved in the immune response and non-immune cells.9, 16, 17, 
20, 21,22 If cytokine production is either excessive or insufficient, infectious, immunological 
and inflammatory diseases may result.22 
Exercise bouts that are intensive and prolonged or that have a strong eccentric 
component, which cause muscle damage, can cause the release of cytokines.22 The first 
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cytokines released are those involved with inflammation, or pro-inflammatory cytokines such 
as IL-1, TNF-7 and IL-6.18, 24, 25, 28 It is thought that pro-inflammatory cytokines are released 
in response to mechanical stress, local ischemia, and/or the production of free radicals in the 
active skeletal muscles; however, the exact mechanisms underlying increased cytokine 
production after exercise remain unknown.21 The release of pro-inflammatory cytokines 
induces the secretion of several molecules from the liver called acute phase proteins.22, 28 
These proteins have several functions, some of which serve to enhance the body’s immune 
response to a pathogen.22 They are also released as a first step towards beginning the process 
of tissue repair.21, 22 
The release of pro-inflammatory cytokines is followed closely by the release of anti-
inflammatory cytokines, such as IL-10 and IL-1ra, which attenuate the inflammatory process 
once it has begun.18, 20, 24, 25, 28 As previously noted, IL-6 has been shown to have aspects of 
both a pro-inflammatory and an anti-inflammatory cytokine.16 It is anti-inflammatory in the 
respect that it may have immune regulatory effects by inhibiting TNF-7,14, 26, 39 and inducing 
upregulation of IL-1ra.20, 38  A balance of pro- and anti-inflammatory cytokines is of the 
utmost importance for the maintenance of a reliable immune system.22 It should be noted 
that, in contrast to intensive prolonged exercise, moderate exercise, such as brisk walking or 
low intensity cycling, does not cause a significant increase in the cytokine levels within the 
blood.22 
 Results of many studies, some of which will be discussed at length in the proceeding 
sections, show significant elevations in cytokine levels after exercise; however, some do not.  
Changes in plasma levels of cytokines are not always seen post-exercise.22  One explanation 
for the lack of observed cytokine response is that they may be produced and act locally only 
12 
within a very small area of the tissue.22 Accessing these sites after exercise may not be 
possible.  A second explanation is that cytokines are rapidly cleared from the blood by 
receptors on both immune cells and non-immune cells.22 This does not mean that cytokines 
are not being produced.  Rather, it means that blood levels may not necessarily reflect 
changes in production, secretion, and activity of a certain cytokine.22 
IL-6 Responses to Exercise
The IL-6 response to exercise of various durations has been studied at length as well.  
Ullum et al.45 investigated the effect of one hour of cycling exercise at 75% of VO2max on 
plasma levels of IL-6 and pre-mRNA for IL-6 in blood mononuclear `cells in seventeen 
moderately trained men.45 Blood samples were taken before exercise, during the last few 
minutes of exercise, and for several hours into recovery.  Results indicated that plasma IL-6 
was significantly increased from during the last few minutes of exercise and levels returned 
to baseline at one hour post-exercise.   Pre-exercise IL-6 was 51 pg/mL.  IL-6 increased to 83 
pg/mL post-exercise, corresponding to an increase of 62.7%.  In addition, pre-mRNA for IL-
6 could be detected in blood mononuclear cells, but, once again, the amounts of mononuclear 
cells did not change in relation to exercise, leading the researchers to conclude that the 
absolute amount of monocytes increases with exercise; however, the increase in plasma 
levels of IL-6 during exercise is not likely to be a result of activated monocytes in peripheral 
blood. 
Haahr et al.10 examined the effect of one hour of cycling exercise at 75% VO2max on 
the production of IL-6. Ten young, healthy volunteers completed the protocol. Blood samples 
were taken before exercise, during exercise, and several hours into recovery in this 
investigation as well.  Results of this study showed that IL-6 significantly increased to ~25 
13 
pg/mL two hours after exercise, followed by a decrease to baseline values, ~15 pg/mL, at 24 
hours post-exercise.  These results indicate that one hour of cycling exercise at 75% VO2max 
significantly influences plasma levels of IL-6 at two hours post-exercise.  
Brenner et al.5 compared the impact of three different types of exercise and seated rest 
on the production of IL-6. Eight healthy male subjects completed five minutes of cycle 
ergometer exercise at 90% of VO2max, a circuit training routine involving biceps curl, knee 
extension, hamstring curl, bench press, and leg press, two hours of cycling at 60% of VO2max 
and five hours of seated rest.  Results of this study indicated significant increases in plasma 
IL-6 from pre-exercise only for the group that completed two hours of cycling at 60% of 
VO2max. Peak values of IL-6 were obtained after three hours of recovery, followed by a 
return to near-baseline at 72 hours post-exercise. Pre-exercise IL-6 was 1.14 ± 0.31 pg/mL 
whereas the peak IL-6 value was 6.06 ± 1.95 pg/mL.  These results led the researchers to 
conclude that two hours of cycling exercise at 60% of VO2max increased plasma levels of IL-
6, showing an activation of components of the inflammatory response.  It is interesting to 
note that in the study by Ullum et al.45, which used one hour of exercise, IL-6 was increased 
in the last few minutes of exercise and reached a baseline only one hour after exercise.   In 
the present study 5, which utilized two hours of exercise, peak values were obtained three 
hours into exercise, and a near-baseline value was not obtained until approximately 24 hours 
post-exercise. 
Nieman et al.21 studied the effect of carbohydrate ingestion and mode of exercise on 
cytokine responses to exercise. Ten experienced triathletes (eight men and two women) were 
broken into carbohydrate or placebo groups, and served as their own controls.  The subjects 
completed four sessions of running or cycling for 2.5 hours at 75% of VO2max under the 
14 
following conditions: running/placebo, running/carbohydrate, cycling/placebo, 
cycling/carbohydrate.  Results showed a post-exercise increase in plasma IL-6 above baseline 
in all four conditions. The lowest immediate post-exercise plasma concentration was 10.7 
pg/mL, and was obtained in the group that consumed carbohydrate and cycled for 2.5 hours.  
In contrast, the highest immediate post-exercise plasma concentration was obtained in the 
placebo group that ran for 2.5 hours, which was 51.6 pg/mL. These results led the researchers 
to conclude that IL-6 increases in both cycling and running exercise at 75% of VO2max and 
that carbohydrate ingestion attenuates the cytokine response.  These results are in agreement 
with those of Ullum et al.45 and Brenner et al.5 discussed earlier. 
Nelson-Cannarella20 also studied the cytokine response to 2.5 hours of high intensity 
running (76.7 ± 0.4% VO2max) in 30 experienced marathon runners (24 men, six women) who 
were split into two groups.  One group consumed a 6% carbohydrate solution during the 2.5 
hours of running, while the other group consumed a placebo solution.  Results of this study 
indicated that plasma IL-6 was significantly increased immediately post-run and remained 
elevated for 1.5 hours post-run for both groups.  The increase; however, was of a lesser 
magnitude for the group that consumed carbohydrate during the run.  The post-exercise 
increases in IL-6 for the carbohydrate and placebo groups were 421 and 753%, respectively.  
Similar to the results of Nieman et al.21, these results indicate that 2.5 hours of high intensity 
exercise increases plasma IL-6; however, carbohydrate attenuates some of the rise in plasma 
IL-6. 
Moldoveanu et al.17 studied the effect of three hours of cycling and inclined walking 
at 60-65% VO2peak on plasma levels of IL-6. Ten healthy, but untrained men were recruited 
for this study; however, cytokines were only analyzed on six of the ten subjects who 
15 
completed the protocol.  Results indicated a significant increase in plasma IL-6 from pre-
exercise to one hour into exercise and three hours into exercise.  Pre-exercise IL-6 was 1.2 
pg/mL. Post-exercise IL-6 was 4.8 pg/mL, which corresponds to an increase of 300% from 
pre-exercise. Plasma concentrations of IL-6 were still significantly elevated at two hours 
post-exercise, but then decreased to baseline levels at 24 hours post-exercise, indicating that 
prolonged exercise at 60-65% VO2peak elevates plasma levels of IL-6.  These results are 
similar to those of Haahr et al.10 and Brenner et al.5, in that levels of IL-6 were still elevated 
above baseline several hours into recovery from exercise. 
Ostrowski et al.24 ivestigated the IL-6 response to a long distance run in ten male 
highly trained subjects.  All subjects completed the Copenhagen Marathon (time range 2:40 – 
4:20) followed by a four hour rest period.  Mean plasma IL-6 peaked at ~75 pg/mL 
immediately after the race and then declined during the four hours of the resting period. The 
recovery levels of IL-6 were declining, but remained significantly different from baseline (~0 
pg/mL) until four hours post-run.  Once again, these results agree with the majority of those 
presented thus far, in that IL-6 stays elevated for several hours into the recovery period after 
exercise.  These results led the researchers to conclude that strenuous exercise induces an 
increase in pro-inflammatory cytokines, specifically IL-6.  The researchers also looked at 
several anti-inflammatory cytokines and found that they had increased during exercise as 
well, indicating that pro-inflammatory cytokines are balanced by an increase in anti-
inflammatory cytokines that restrict the duration of the inflammatory response. 
Gannon et al.9 studied the effect of prolonged and strenuous cycling in six amateur 
cyclists on the IL-6 response. All of the subjects completed a 250-km road race (race time: 
404.0 ± 3.5 minutes).  Plasma IL-6 concentrations were approximately doubled at 10-25 
16 
minutes after completion of the road race, and, again were still elevated 150 minutes into 
recovery from the race.  These results led the investigators to suggest that performance in a 
road race lasting approximately 6.5 hours increases plasma levels of IL-6 and induces a pro-
inflammatory cytokine response. 
 The studies discussed in this section agree that exercise is a stimulus that increases 
circulating plasma levels of IL-6; however they do not include the source of the IL-6.  
Steensberg et al. investigated the IL-6 response to five hours of one-legged dynamic knee 
extensor exercise.40 One leg performed the exercise, which represented 40% of peak power 
output, while the other leg remained stationary.  Results of this study showed that the net IL-
6 measured in the exercising leg increased dramatically from 0.74 ng/L to 14.13 ng/L after 
five hours, whereas the resting leg had an unchanged net IL-6 release, leading these 
researchers to conclude that IL-6 is released exclusively from the contracting muscle during 
exercise.  
TNF-7 Responses to Exercise
The TNF-7 response to exercise of various durations has been studied at length.  
Ullum et al.45 investigated the effects of cycling exercise on plasma levels of cytokines and 
pre-mRNA for cytokines in blood mononuclear cells. Seventeen healthy moderately trained 
men completed one hour of cycle ergometer exercise at 75% of VO2max. Results indicated 
that post-exercise plasma TNF-7 was below the detection limit in most subjects. In addition, 
pre-mRNA for TNF-7 could be detected in blood mononuclear cells, but the amounts did not 
change in relation to exercise, leading these researchers to conclude that one hour of cycling 
exercise performed at 75% of VO2max does not increase plasma TNF-7.
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Haahr et al.10 performed an experiment very similar to that of Ullum et al.45, and 
observed very similar results. In this experiment, ten young, healthy volunteers completed 
one hour of cycling exercise at 75% VO2max. Results of this investigation showed that blood 
levels of TNF-7 did not change from pre- to post-exercise.  There were also no changes at 
two hours post-exercise and 24 hours post-exercise, indicating, once again, that one hour of 
cycling exercise at 75% VO2max does not influence blood levels of TNF-7; however, Zack 48 
has shown that 30 minutes of submaximal exercise has been a sufficient stimulus to cause an 
increase in the amount of circulating plasma TNF-7.
Brenner et al.5 compared the impact of strenuous all-out exercise, circuit training, and 
two hours of exercise on TNF-7 production. Eight healthy male subjects completed exercise 
under four conditions: five minutes of cycle ergometer exercise at 90% of VO2max, a circuit 
training routine involving five different exercises (biceps curl, knee extension, hamstring 
curl, bench press, and leg press), two hours of cycling at 60% of VO2max and five hours of 
seated rest.  For purposes of this review, the focus is only on the two hours of cycle 
ergometer exercise performed at 60% of VO2max. Results of this study indicated significant 
increases from pre-exercise plasma TNF-7 for two hours of cycling at 60% of VO2max. Pre-
exercise TNF-7 was 1.05 ± 0.13 pg/mL.  Peak values of 1.87 ± 0.27 pg/mL were obtained 
after 72 hours of recovery.  These results led the researchers to conclude that two hours of 
prolonged cycling exercise at 60% of VO2max increases plasma levels of TNF-7; thus, 
activating components of the inflammatory response.  These results are contrary to those of 
Ullum et al.45 and Haahr et al.10, which utilized only one hour of exercise.    
Dufaux and Order 7 investigated the TNF-7 response to 2.5 hours of running 
(marathon) in eight healthy male subjects. Results indicated a significant increase in plasma 
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TNF-7 one hour after the cessation of exercise (~27 pg/mL vs. ~17 pg/mL pre-exercise), but 
not immediately post-exercise (~21 pg/mL).  Plasma concentrations of TNF-7 were still 
elevated at both three hours post-exercise and at 24 hour post-exercise.  These results 
indicate that 2.5 hours of running exercise is sufficient to evoke a TNF-7 response and that 
there is involvement and activation of parameters of the inflammatory response after 
prolonged exercise.  The results obtained in this experiment differ from those obtained by 
Brenner et al.5 in that there was no significant increase in plasma TNF-7 immediately post-
exercise. 
Moldoveanu et al.17 studied the effect of three hours of cycling and inclined walking 
at 60-65% VO2peak in ten healthy, but untrained men. Plasma cytokine level were only 
analyzed in six of the ten subjects who completed the protocol.  Results of this study 
indicated a significant increase from pre-exercise TNF-7 at one hour into exercise and at the 
completion of exercise.  Pre-exercise TNF-7 was 1.0 pg/mL, which increased to 1.2 and 1.9 
pg/mL after 60 and 180 minutes, respectively.  These concentrations decreased at two hours 
and 24 hours post- exercise; however, they were still significantly higher than the initial 
baseline value, indicating that prolonged exercise at 60-65% VO2peak elevates plasma levels 
of TNF-7. The results of this study both agree with and contradict the results of other 
investigations. These results are similar in that TNF-7 was significantly elevated above 
baseline immediately post- exercise5, and several hours into recovery.5,7 They are 
contradictory; however, because significant differences in plasma TNF-7 were observed after 
only one hour of exercise at 60-65% in this study, whereas in the studies discussed by Ullum 
et al.45 and Haahr et al.10, no significant differences were found for one hour of exercise 
performed at 75% of VO2max.
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Ostrowski et al.24 studied the TNF-7 response to strenuous exercise in ten highly 
trained male subjects. All of the subjects completed the Copenhagen Marathon (time range 
2:40 – 4:20) followed by a four hour rest period.  Similar to the results of both Brenner et al.5
and Moldoveanu et al.17, mean plasma TNF-7 peaked immediately after the race (2-3 fold 
increase) and then declined during the four hours of the resting period. Despite the fact that 
the plasma levels of TNF-7 were declining, they remained significantly elevated from 
baseline until 2.5 hours after the completion of the marathon.  These results led the 
researchers to conclude that strenuous exercise induces an increase in plasma TNF-7.
Finally, Gannon et al.9 studied the effect of prolonged and strenuous cycling on TNF-
7 as well. Six amateur cyclists completed a 250-km road race (race time: 404.0 ± 3.5 
minutes).  Plasma TNF-7 concentrations were approximately doubled at 10-25 minutes and 
150 minutes after completion of the competition.  These results led these investigators to 
suggest that performance in a road race lasting approximately 6.5 hours increases plasma 
levels of TNF-7 and induces a pro-inflammatory cytokine response.   
Timmons43 recently reviewed immunological changes in children that occur with 
exercise and suggested that IL-6 produced during exercise may function as an antagonist to 
TNF-7. He notes that TNF-7 is expressed in, but not released from skeletal muscle during 
contraction, and so the ratio of IL-6 to TNF-7 may be a useful marker of the inflammatory 
environment during and following exercise. 
Summary
Cytokines are molecules which are produced by and mediate communication between 
and within immune and non-immune cells, organs, and organ systems throughout the body.10, 
16, 17,18, 22 Cytokines are classified as either pro-inflammatory or anti-inflammatory, and a 
20 
balance between the two types is of the utmost importance for the maintenance of a reliable 
immune system.22 Following an intensive prolonged bout of exercise, pro-inflammatory 
cytokines such as IL-1, TNF-7 and IL-6 are released.16, 18 , 22 These cytokines are 
responsible for inducing the secretion of acute phase proteins which are involved with 
augmenting the body’s immune response to a pathogen and beginning the process of tissue 
repair.22 
Anti-inflammatory cytokines, such as IL-10 and IL-1ra, are released shortly after pro-
inflammatory cytokines. As previously noted, the IL-6 released shortly after the onset of 
exercise can also be considered an anti-inflammatory cytokine in that it may have immune 
regulatory effects by inhibiting TNF-7,14, 26, 39 and inducing upregulation of IL-1ra.20, 39 
These anti-inflammatory cytokines are involved in attenuating the inflammatory process once 
it has begun.16, 22 The literature on single sessions of exercise (some of great duration) show 
that major pro-inflammatory cytokines, TNF-7 and IL-6, increase following exercise, and, in 
most cases, remain elevated for several hours, even days, into the recovery period.  However, 
the responses of TNF-7 and IL-6 to multiple sessions separated by 24 hours of recovery are 
unknown.
CHAPTER III 
 
Methodology 
 
This study consisted of five total visitation sessions for each participant (see Figure 
3).  The first session was an orientation session, which was followed by four consecutive 
days of testing each separated by 24 hours.  In the orientation session, the protocols were 
explained, participant characteristics were obtained, and peak oxygen consumption, VO2peak,
was determined.  Sessions I, II and III were Intensive Training Trials in which participants 
performed 60 minutes of cycling at 75%VO2peak. Baseline and immediate post-exercise 
blood samples were taken to determine IL-6 and TNF-7 concentrations.  In Session IV, the 
participant had a resting, baseline blood sample taken to determine IL-6 and TNF-7
concentrations.  No exercise was performed in this final session. 
 
Figure 3. General outline of the experimental protocol used in the study.   
 Orintation  
Session Session I  Session II   Session III Session IV 
Orientation  
VO2peak Intensive Training 
Trial 1 
Intensive 
Training 
Trial 2 
Intensive 
Training 
Trial 3 
Rest  
Day 
 ~1 Week 24 Hours 24 Hours 24 Hours 
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Participants
Highly trained male endurance athletes, 18 to 45 years of age, were recruited for this 
study.  In order to be included in this study, participants had to be training for a minimum of 
five days per week for a minimum of 60 minutes each day and had to be current participants 
in competitive sporting events such as marathon, triathlon or cycling competition.  In 
addition, all participants were willing to consume a glucose polymer supplement, Polycose®,
on the day preceding the Intensive Training Trials, as well as on the days of the Intensive 
Training Trials.  If any of the following were present, participants were excluded: history of 
any chronic medical conditions or orthopedic injury, history of infection in the six weeks 
period prior to the study, and use of any medications, including all non-steroidal anti-
inflammatory drugs such as Aleve®, Advil®, Bayer®, Celebrex®, etc.  Each participant was 
informed of the experimental protocol, made aware of the possible risks and signed an 
informed consent prior to participation. All participants refrained from strenuous physical 
activity for 24 hours prior to VO2peak testing and 24 hours prior to the start of the Intensive 
Training Trials.  In addition, participants were asked to reduce training to an “easy” level two 
days prior to the start of the Intensive Training Trials in order to mimic a typical “micro-
cycle”1. Participants did not perform any physical activity on the days of the Intensive 
Training Trials. Finally, participants did not eat, smoke or consume alcohol and caffeine 
eight hours prior to Sessions I-IV.  
Instrumentation
Height was determined to the nearest 0.01 cm using a portable standiometer 
(Perspective Enterprises, Portage, MI).  Body mass was determined to the nearest 0.01 kg 
using a calibrated mechanical scale (Detecto, Webb City, MO).  Skinfolds were measured to 
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the nearest ) 0.5 mm using a Lange skinfold caliper (Model 68902, Cambridge Scientific 
Industries, Inc., Cambridge, MA).  Peak oxygen consumption was determined during a 
continuous, incremental cycling test on a Monark Ergomedic 894 E cycle ergometer (Monark 
Exercise, Sweden).  Respiratory gases were obtained for the orientation session, as well as all 
Intensive Training Trials using the Parvo Medics TrueMax 2400 Metabolic System (Parvo 
Medics, Salt Lake City, UT).  Heart rate was monitored continuously using the Polar 
telemetry system (Polar Electro Inc., Lake Success, NY).  Ratings of perceived exertion were 
determined using Borg’s original 6-20 scale.3 Hematocrit was determined using an Adams 
MHCT II microhematocrit centrifuge (Becton Dickinson, Frankin Lakes, NJ) and an 
International Microcapillary Reader (International Equipment Company, Needham Heights, 
MA).  Hemoglobin was determined from absorbance values obtained using a Milton Roy 
Spectronic 1201 flow through cell spectrophotometer (Milton Roy, Ivyland, PA).  Whole 
blood samples were placed in an IEC Centra-8R refrigerated centrifuge (International 
Equipment Company, Needham Heights, MA) and the resultant plasma was stored.  Plasma 
TNF-7 and IL-6 were measured using high-sensitivity enzyme-linked immunosorbent assay 
kits (ELISA; Cell Sciences, Canton, MA ).  Cytokine assays were read with a Finstruments 
Microplate reader (Model 310, MTX Lab Systems Inc., Vienna, VA) with Spectra software 
analysis (MTX Lab System Inc., Vienna, VA).  Lactate and total CK were measured using 
the Vitros DT60 II (Ortho-Clinical Diagnostics, Rochester, NY).   
Protocol
Orientation Session 
The participant arrived at the Applied Physiology Laboratory and was be informed of 
the experimental protocol, made aware of the possible risks associated with the protocol, and 
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signed an informed consent.  After consenting to participate in the experiment, the participant 
underwent a medical screening, including a 12 lead electrocardiogram, and a physical 
screening.  After the participant was deemed fit to participate in the experiment, physical 
characteristics, including height, weight and age were obtained.  Percent body fat was 
determined from the sum of skinfolds using the method of Jackson and Pollock.13 
Following collection of participant characteristics, VO2peak was determined during a 
continuous, incremental cycling test on a cycle ergometer.  The cycle ergometer was fitted to 
the participant to ensure that he was comfortable and could perform the VO2peak protocol 
without injury.  The participant completed a 10 minute warm up which consisted of five 
minutes of cycling at a resistance of 50 watts (W) followed by five minutes of stretching 
focused on the lower body musculature.  After warm up, resting oxygen consumption (VO2)
was recorded for four minutes.  The participant then began cycling at 50W. Resistance was 
increased by 50W every three minutes for 12 minutes.  Resistance was then increased by 25 
W every minute thereafter until volitional fatigue (see Figure 4).15, 38 Heart rate (HR) and 
respiratory gases were monitored continuously for the entire duration of the VO2peak 
determination.  HR and rating of perceived exertion (RPE) were recorded at the end of each 
stage of the protocol.  The participant was provided with strong verbal encouragement during 
the entirety of the test.  At the conclusion of the test, the participant was allowed to recover 
actively or passively. Participants were deemed safe to leave the laboratory once HR less 
than or equal to 100 beats per minute (bpm).  For the VO2peak test to be considered valid, the 
participant had to achieve a respiratory exchange ratio (RER) equal to or greater than 1.1, a 
HR equal to or greater than the age predicted maximal heart rate (220-age ± 5%), and had to 
report an RPE equal to or greater than 18.15 A power output estimated to require 75% of 
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VO2peak was determined from a linear regression equation which plotted steady state oxygen 
consumption (VO2) values against the corresponding workloads.15 Prior to the conclusion of 
the orientation session, participants were given a canister of Polycose® glucose polymer 
(Ross Products, Columbus, OH) and were instructed to consume 25% of the canister (~90g) 
on the day prior to the start of Session I, and an additional 25% of the canister on the days of 
Sessions I, II and III.  Upon completion of the exercise protocol, participants were asked to 
return the empty canister to the investigators to ensure compliance with the participant 
instructions.  Polycose® glucose polymer, a carbohydrate supplement, was given to the 
participants due to the fact that research has shown that decreased carbohydrate intake can 
potentially increase the cytokine response to exercise.21 
Sessions I-III: Intensive Training Trials. 
At least one week after determination of VO2peak, participants reported to the Applied 
Physiology Laboratory for three consecutive days of Intensive Training Trials.  Two days 
prior to the first Intensive Training Trial, participants were instructed to complete an “easy” 
day of training.  The day before the first Intensive Training Trial, participants were instructed 
to rest.  No exercise of any kind was permitted on the day before the first Intensive Training 
Trial.  In addition, participants completed a food diary for the day preceding Session I, as 
well as on the days of Sessions I, II, and III.  Participants arrived after an overnight fast 
(minimum of 8 hours) to complete each Intensive Training Trial, which was performed in the 
morning, between the hours of 6:30 A.M. and 11:00 A.M. on each day.  The time at which 
each participant arrived for Session I was replicated for Sessions II, III and IV.  This was 
done in order to minimize differences in hormonal concentrations across the Intensive 
Training Trials for each of the participants. 
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Upon arrival, participants were asked if they complied with the guidelines set by the 
investigators, and verbal responses were recorded.  In addition, dietary logs were collected 
prior to the start of each session and examined to ensure that participants were consuming 
adequate calorie and carbohydrate to complete the exercise tasks.  After compliance was 
confirmed, participants rested in the supine position for ten minutes. After ten minutes of 
rest, three mL of venous blood were obtained using the standard Venipuncture technique.  
The blood sample was placed into a sterile K2 - EDTA (purple top) Vacutainer® tube and 
immediately put on ice.  After resting blood sampling, participants performed a ten minute 
warm up consisting of five minutes of cycling followed by five minutes of stretching focused 
on the lower body musculature.  After warm up, resting oxygen consumption was recorded 
for four minutes (see Figure 4).  The participants then cycled for 60 minutes at the previously 
determined workload that elicits 75% of VO2peak. Sixty minutes of cycling exercise was 
chosen in order to mimic a typical athletic training regimen.  HR and RPE were monitored 
continuously and recorded at minutes 0, 10, 20, 30, 40, 50 and 60.  Oxygen consumption was 
measured from minutes 16-20, 36-40 and 56-60.  Water was ingested ad libidum by the 
participants for all of the Intensive Training Trials.  Upon completion of the 60 minutes of 
cycling exercise, a three mL blood sample was obtained and immediately put on ice.  After 
blood sampling, participants were deemed safe to leave the laboratory once HR was less than 
or equal to100 bpm. 
Session IV: Rest Day 
Twenty four hours after completion of the third Intensive Training Trial, participants 
returned to the Applied Physiology Laboratory between the hours of 6:30 A.M. and 11:00 
A.M. for a final, resting blood sample. Upon arrival, participants rested in the supine position 
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for ten minutes. After the rest period, a three mL blood sample was obtained using the 
standard Venipuncture technique, placed in a purple top Vacutainer® tube and immediately 
put on ice.   
Figure 4. Outline of the three identical Intensive Training Trials (Sessions I, II, and III) used 
in the study.  
 
Blood Procedures
Hematocrit 
Resting and post-exercise Hematocrit (Hct) values for each of the three Intensive 
Training Trials were determined in triplicate from blood samples.  Whole blood was drawn 
into 75 mm microhematocrit capillary tubes (Fisher Scientific International Inc., Hampton, 
NH) and sealed using Critoseal (Krakeler Scientific, Inc., Albany, NY).  Capillary tubes were 
then be spun in a microhematocrit centrifuge for three minutes at 10,000 RPM.  After three 
minutes, the capillary tubes were removed from the centrifuge and placed on a hematocrit 
wheel to determine the ratio of formed elements to plasma in each sample.  A mean of the 
three hematocrit determinations from each whole blood sample was calculated and used in 
data analysis. 
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Hemoglobin 
Resting and immediate post-exercise Hemoglobin (Hb) values were determined in 
triplicate from the blood samples for each of the three Intensive Training Trials by using the 
cyanmethemoglobin technique.  Twenty JL of whole blood were placed into five mL of 
cyanmethemoglobin for each sample. Samples were then drawn into a flow through cell 
spectrophotometer and an absorbance value was obtained for each.  The amount of Hb
present in each sample was determined mathematically via regression analysis using Beers 
Law, and a mean was calculated for use in data analysis. 
Plasma Volume Shift 
Exercise-induced changes in plasma volume were calculated from Hct and Hb values 
according to the method described by Dill and Costill.6 Plasma volume shift was used as a 
potential explanatory variable for changes in cytokine concentrations, and is not a primary 
outcome measure. 
Cytokines 
Whole blood was centrifuged at 3,000 g for 10 min at 4°C. The resultant plasma 
portion was transferred to Eppendorf tubes (Eppendorf North America, New York, NY) and 
stored at 80°C until cytokine analyses were conducted.  Plasma levels of TNF-7 and IL-6 
were measured using high-sensitivity enzyme-linked immunosorbent assay kits (ELISA; Cell 
Sciences, Canton, MA ).  Sensitivity of the TNF-7 assay was <2.0 pg/mL.  Sensitivity of the 
IL-6 assay was < 0.8 pg/mL.  All cytokine assays were performed in triplicate and intra-assay 
coefficients of variation were calculated (For details, see Appendix D). 
 
29 
Additional Blood Measures 
To assess the participants level of physical stress during the Intensive Training Trials, 
lactate and total creatine kinase (CK) were measured.11 Lactate and total CK were measured 
using the Vitros DT60 II (Ortho-Clinical Diagnostics, Rochester, NY).  All assays were 
performed with duplicate determinations. 
Data Analysis
Data was analyzed using SPSS statistical software (Version 14.0, Chicago, IL). 
Statistical significance for all analyses was set at 7 < 0.05. Descriptive statistics were 
presented as means ± standard deviations (SD).   
To examine the cardiovascular and respiratory responses (VO2, heart rate, RPE and 
plasma volume shift) to the Intensive Training Trials (Sessions I, II and III), a repeated 
measures Analyses of Variance (ANOVA) with Bonferroni adjusted t-tests was performed.  
These analyses were used to investigate whether or not participants were exercising at a 
physiological steady state for the 60 minutes of exercise in each of the Intensive Training 
Trails, and to determine if there were any significant differences in mean cardiovascular and 
respiratory responses between exercise in Sessions I, II and III. Additionally, to examine the 
participants’ level of physical stress during the Intensive Training Trials, a repeated measures 
ANOVA with Bonferroni adjusted t-tests was performed with the creatine kinase (CK) and 
lactate data obtained. 
To determine the acute effect of exercise on cytokine concentrations (hypotheses 1 
and 4), a 3 X 2 (3 intensive training trials X 2 blood sampling times) completely repeated 
measures ANOVA analysis with Bonferroni adjusted t-tests was performed.  To determine 
the cumulative effect of exercise on cytokine concentrations (hypotheses 2 and 4), three 
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percent change (%H) scores were computed for both IL-6 and TNF-7, for a total of six %H
scores.  The first set of %H scores assessed changes in IL-6 and TNF-7 from rest to 
immediate post-exercise in Session I.  The second set of %H scores assessed changes in IL-6 
and TNF-7 from rest to immediate post-exercise in Session II.  The third %H score assessed 
changes in IL-6 and TNF-7 from rest to immediate post-exercise in Session III.  All %H
scores were computed using the formula: 
%H = {(Post-exercise – Pre-exercise)/ Pre-exercise}X 100 
A one way (1 change score X 3 intensive training trials) repeated measures ANOVA 
analysis with Bonferroni t-tests was then performed.  To determine if there were significant 
differences in the mean resting cytokine concentrations over the the three Intensive Training 
Trials and the rest day (hypotheses 3 and 6), a one way (1 blood sampling time X 4 days of 
measurement) repeated measures ANOVA with Bonferroni adjusted t-tests was performed.   
 Finally, the pre-exercise and post-exercise IL-6:TNF-7 ratios were computed for each 
participant by dividing the IL-6 values obtained by the TNF- 7 values obtained.  The 
resultant number was then multiplied by 100 to make the ratio into a percentage.  The 
formula used in computing the IL-6:TNF-7 ratio can be seen below: 
 IL-6:TNF-7 ratio = (IL-6/TNF-7) * 100
A 3 X 2 (3 intensive training trials X 2 blood sampling times) repeated measures 
ANOVA with Bonferroni adjusted t-tests was performed in order to determine the acute 
effect of exercise on the IL-6:TNF-7 ratio. To determine if there were significant differences 
in the mean resting IL-6:TNF-7 ratio over the course of the three Intensive Training Trials 
and the following rest day, a one way (1 blood sampling time X 4 days of measurement) 
repeated measures ANOVA analysis with Bonferroni adjusted t-tests was performed.  
CHAPTER IV 
Results 
 
Participant Characteristics
Twenty highly trained male endurance athletes were recruited for participation in this 
study.  Seven of the 20 participants completed all aspects of the protocol (Table 2).  Prior to 
participation in this study, all participants were briefed on the nature of the study, made 
aware of the possible risks associated with the protocol, and gave written informed consent to 
act as human subjects.    
Table 2. Physical characteristics of the participants (n=7). Values are Means (± SD). 
 
All participants met the inclusion criteria; i.e., they were currently training for a 
minimum of five days per week for a minimum of 60 minutes per day, and were participating 
in or training for competitive sporting events such as triathlons, marathons, and cycle 
competitions, etc.  All participants complied with the experimental guidelines set by the 
investigators (see Methods chapter). 
Measure Mean ± SD Range 
Age 
(yr) 29.1 ± 7.0 22.0 – 42.0 
Height 
(cm) 180.7 ± 7.4 173.0 – 191.5 
Mass 
(kg) 78.8 ± 4.7 72.0 – 86.3 
Body Fat 
(%) 13.8 ± 2.6 11.3 – 17.5 
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VO2peak Testing
Four of the seven participants met the criteria for a valid VO2peak test (see Methods 
chapter). For these participants, oxygen consumption peaked at the end of the test and then 
decreased, indicating that peak oxygen consumption had been reached, leading the 
researchers to conclude that the test was valid.  
The mean absolute VO2peak obtained was 4.7 ± 0.8 L/min (range of 3.3 – 5.9 L/min) 
and relative VO2peak obtained was 59.7 ± 7.7 ml/kg/min-1 (range of 45.8 – 68.3 ml/kg/min-1). 
Mean VO2peak test time was 19.0 ± 2.8 minutes in duration (range of 14.0 to 23.0 minutes). 
The mean maximal workload completed by the participants was 360.7 ± 55.6W (range of 
250.0 – 425.0W).   
Intensive Training Trials
Each participant completed three submaximal Intensive Training Trials separated by 
approximately 24 hours with a subsequent resting only trial (Session IV), 24 hours after the 
third Intensive Training Trial.   
Basic Physiological Responses 
Each Intensive Training Trial was to consist of 60 minutes of cycling at 75% of 
VO2peak. The actual mean trial workload was 218.6 ± 42.3W, which elicited a mean VO2 of 
3.4 ± 0.6 L/min, corresponding to 71.3 ± 8.0 % of VO2peak.
The VO2 responses of the participants indicate that they were working at a 
physiological steady state for the duration of each of the 60 minute Intensive Training Trials 
(see Table 3).  ANOVA results revealed no significant differences from the start of exercise 
(20 minutes) through the completion of 60 minutes of exercise for all of the Intensive 
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Training Trials, indicating a steady state VO2 for the duration of the Intensive Training Trials 
(p > 0.05).  
 The HR results of the participants; however, indicate that they were working at a 
physiological steady state for some, but not all of the Intensive Training Trials (see Table 3). 
ANOVA results showed a significant session X time interaction for HR.  Post Hoc analyses 
indicate no significant differences in the resting HR of the participants for Sessions I, II and 
III (p > 0.05). Post Hoc analyses; however, revealed a significantly higher HR during 
minutes 30 and 60 of Session II than minutes 30 and 60 of Session III (p = 0.038 and p = 
0.020, respectively).  Finally, analyses revealed a significantly higher HR at minute 60 of 
Session II than at minute 10 of Session II (p = 0.001).  
No significant interaction was found for RPE; however, ANOVA results indicated a 
significant main effect for time (p = 0.001). Post Hoc analyses indicated significantly higher 
mean RPE at minutes 30, 40, 50 and 60 than at minute 10 of exercise (p = 0.001).  In 
addition, Post Hoc analyses revealed a higher mean RPE at minutes 40, 50, and 60 of 
exercise than at minute 20 of exercise (p = 0.015, p = 0.009 and p = 0.030, respectively).   
Finally, plasma volume declined during Sessions I, II and III.  Mean plasma volume 
loss for Sessions I, II and III were -17.2 ± 5.6%, -18.8 ± 3.8% and -18.3 ± 6.6% over the 60 
minutes of exercise, respectively. There were, however, no significant differences in mean 
plasma volume loss between each of the training Sessions (p > 0.05). 
Pre-exercise, post-exercise and percent change values for CK can be found in Table 
5. ANOVA results indicate a significant session X time interaction for CK (p = 0.04).  Post 
Hoc analyses reveal significant increases in mean CK from pre-to post-exercise for Session I, 
Session II and Session III (p = 0.005, p = 0.001 and p = 0.002, respectively).  Mean CK 
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concentrations can be seen in Table 5. ANOVA results; however, indicate no significant 
differences in the percent change in CK for sessions I, II and III (p > 0.05). ANOVA results 
also indicate significant differences in mean baseline concentrations of CK (p = 0.04). Post 
Hoc analyses indicate a significantly higher baseline CK concentration for Sessions III and 
IV than for Session I (p = 0.008 and p = 0.006, respectively). Baseline values of CK can be 
found in Table 5.  
ANOVA analysis was performed in order to assess changes in post-exercise lactate 
concentration.  Pre-exercise lactate was not examined because it is widely accepted that 
blood lactate concentrations are approximately 1.0 mmol/L.34 ANOVA results reveal no 
significant differences in mean post-exercise blood lactate concentration (p > 0.05).  
Assuming the pre-exercise values were approximately 1.0 mmol/L, this means that blood 
lactate increased from pre- to post-exercise for Sessions I, II and III; however, the increases 
were all substantially elevated and were of the same magnitude, which confirms the intensive 
level of the exercise.  Post-exercise lactate concentrations can be seen in Table 5.   
Primary Outcome Blood Responses 
IL-6. The intra-assay coefficient of variation for the IL-6 assay was 6.99 %.  Quality control 
standards were within 10% of determined values, suggesting the assay displayed a high level 
of accuracy. 
Pre-exercise and post-exercise values for IL-6 can be found in Table 4. ANOVA 
results indicated a significant main effect of time for IL-6 (p = 0.002). Mean pre-exercise IL-
6 was measured as 4.43 ± 2.67 pg/mL. After 60 minutes of exercise, IL-6 rose to 8.23 ± 3.67 
pg/mL, which represents an increase of 85.78%.  There was no session X time interaction (p 
> 0.05).  
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Percent change and baseline values of IL-6 can be found in Table 4.  ANOVA results 
show no significant differences in the percent change of IL-6 across the three days of 
intensive training (p > 0.05).  In addition, ANOVA results indicated that there were also no 
significant differences in the baseline values of IL-6 over the course of Sessions I-IV (p > 
0.05).   
TNF-7. The intra-assay coefficient of variation for the TNF-7 assay was 7.15%.  Quality 
control standards were within 10% of determined values, suggesting the assay displayed a 
high level of accuracy. 
ANOVA results indicated no significant main effects or session X time interaction for 
TNF-7 (p > 0.05).  Mean pre-exercise TNF-7 was 217.38 ± 529.16 pg/mL. Post-exercise 
TNF-7 was 238.13 ± 578.63 pg/mL, which corresponds to an increase of only 9.55. In order 
to decrease the variability within the data, a log transformation of the TNF-7 concentrations 
was performed, and the ANOVA analysis repeated.  Results of the ANOVA using the log 
transformation data indicated a significant session X time interaction (n = 7, p = 0.001).  Post 
Hoc analyses show that TNF-7 increased from pre- to post-exercise in both Session II and 
Session III (p = 0.001 and p = 0.017, respectively), but not Session I. 
Pre-exercise and post-exercise TNF-7 concentrations can be found in Table 4, and are 
depicted in Figure 6.  The ANOVA analysis was repeated with the outlier subject data 
completely removed.  Once again, results show a significant session X time interaction (n = 
6, p = 0.001). Post Hoc analyses reveal a significant increase in mean TNF-7 from pre- to 
post-exercise for both Sessions II and III (p = 0.001 and p = 0.010, respectively).   
Percent change for TNF-7 can be found in Table 4.  ANOVA results show significant 
differences in the percent change of TNF-7 across the three Intensive Training Trials (n = 7, 
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p = 0.001).  Post Hoc analyses indicate that the percent change was significantly higher for 
Session II than for Session I (p = 0.001).  Once again, the outlier subject data for TNF-7 were 
removed and the ANOVA repeated. Analysis without the outlier subject data also indicates a 
significant difference in the percent change in TNF-7 across the three Intensive Training 
Trials (n = 6, p = 0.001). Post Hoc analyses show that the change in mean TNF-7 was 
significantly higher for Session II than for both Session I and Session III (p = 0.001 and 
0.006, respectively), indicating that the magnitude of change in TNF-7 was the greatest for 
Session II, which supports the data from the ANOVA analysis with seven subjects.   
Baseline values for TNF-7 can be found in Table 4. The ANOVA analysis also 
indicated that there were no significant changes in baseline TNF-7 over Sessions I-IV (n = 7, 
p > 0.05).  As with previous TNF-7 analyses, the outlier subject data were removed, and the 
ANOVA analysis for baseline TNF-7 repeated.  Results of the analysis without the outlier 
data for TNF-7 showed a significant main effect for session, indicating a significant 
difference in baseline concentration of TNF-7 over the course of Sessions I-IV (n = 6, p = 
0.003).  Post Hoc analyses revealed significantly higher baseline concentrations of TNF-7 for 
Session IV than for Session II (p = 0.002). 
IL-6:TNF-7 Ratio. ANOVA results show a significant main effect for time of the IL-6:TNF-
7 Ratio percentage (n = 7, p = 0.005).  The mean pre-exercise IL-6:TNF-7 ratio was 21.22 ± 
15.98%.  Post-exercise, this ratio increased to 34.14 ± 20.18%, a 1.6 fold increase.  As with 
all analyses involving TNF-7, the outlier subject data were removed, and the ANOVA 
repeated. ANOVA results with the outlier data removed also indicate a main effect for time 
of the IL-6:TNF-7 Ratio (n = 6, p = 0.002). The mean pre-exercise IL-6:TNF-7 ratio with the 
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outlier subject data removed was 24.69 ± 15.47%. Post-exercise, this ratio increased to 39.69 
± 16.36%, a 1.6 fold increase. Values of the IL-6:TNF-7 ratio can be found in Table 4. 
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Table 3. Mean (± SD) VO2, HR, and RPE for Sessions I, II and III. Dashed lines (---) 
indicate that measurements were not recorded during that time period. * Indicates a 
significantly lower VO2 than minutes 20, 40 and 60 (p < 0.001).  § Indicates a significantly 
higher HR than for the corresponding time in Session III (p < 0.03)‡ Indicates a significant 
difference in RPE from minute 10 within the session (p < 0.001). † Indicates a significant 
difference in RPE from minutes 20 within the session (p < 0.03). 
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Table 4. Mean (± SD) pre-exercise (baseline) values, post-exercise values, and calculated 
percent change (%H) for IL-6, TNF-7 and the IL-6:TNF-7 ratio. Dashed lines (---) indicate 
that measurements were not calculated.  Note: The values presented for TNF-7 are means ± 
SD for the ANOVA with the outlier subject data removed (n = 6). * Indicates a significantly 
higher post-exercise value (p < 0.01). § Indicates a significantly higher %H than Session I 
and Session III (p < 0.006). ‡ Indicates a significantly higher baseline than Session II (p < 
0.002).  
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Table 5. Mean (± SD) pre-exercise (baseline) values, post-exercise value and percent change 
(%H) for CK and Lactate.  Dashed lines (---) indicate that measurements were not recorded 
during that time period. * Indicates a significant increase from baseline values within the 
session (p < 0.004).  § Indicates a significantly higher baseline than Session I (p < 0.008). 
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Figure 6. Mean (± SE) TNF-7 response to exercise. * Indicates a significant increase in TNF-
7 from pre to post-exercise (n = 6, p < 0.01).  
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CHAPTER V 
Discussion 
 
The purposes of this experiment were to determine the acute and cumulative 
responses of IL-6 and TNF-7 to three days of intensive training (i.e. training micro-cycle), 
and to determine if there were differences in baseline values of IL-6 and TNF-7 during the 
three days of intensive training.  The investigator hypothesized that each cytokine would 
increase from pre-exercise to post-exercise, that the change in each cytokine would be of  
greater magnitude with each successive bout of intensive training, and that resting 
concentrations of each cytokine would be significantly elevated following each Intensive 
Training Trial.  In order to test these hypotheses, seven highly trained male athletes 
completed a VO2peak test, followed by three days of steady state cycling at ~75% VO2peak 
separated by approximately 24 hours, and a subsequent rest day assessment.   
Exercise Responses
The workloads at which the participants cycled elicited a mean VO2 of 71.3 ± 8.0 % 
of VO2peak across the three days, which is slightly lower than the goal of 75% of VO2peak. The 
workloads to elicit the 75% were determined from regression analysis of VO2peak results. This 
variability between desired intensity and actual elicited responses, while not ideal, are within 
the error of the regression technique. Any workload adjustments made during Session I were 
repeated for Session II and Session III to ensure that the workloads were identical for all of 
the Intensive Training Trials. Despite the fact that the trial workloads were held constant, 
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some measures varied within each session and from day to day.  Lactate and CK responses 
suggest that all of the Intensive Training Trials were equally difficult.  Similarly, VO2 results 
indicated the three Intensive Training Trials were of a comparable difficulty, and that the 
participants were working at steady-stateVO2 for each; however, HR and RPE responses did 
not show steady state responses. 
Results showed that mean HR measured at minutes 30 and 60 of Session II were 
significantly higher than minutes 30 and 60 of Session III, indicating that two time points in 
Session II were more physiologically taxing than the same time points in Session III.  In 
addition, the HR results also indicated that the end of exercise (minute 60) was significantly 
more physiologically taxing than the beginning of Session II (minute 10), meaning HR was 
not at physiological steady-state for the duration of Session II.  It is likely that this increase in 
HR at the end of Session II was due to cardiovascular drift and plasma volume loss. 
Interestingly, all subjects verbally indicated that they perceived Session II to be the most 
difficult of all of the Intensive Training Trials, and noted that Session III was substantially 
easier than Session II, which is supported by the HR data.  
Additionally, RPE results suggest that the second half of each of the Intensive 
Training Trials was perceived as more difficult than the first half of each of the trials.  These 
results show the workloads of three trials were the same for each of the three days, in that the 
responses for all three of the Intensive Training Trials were similar.  Despite the fact that the 
workloads elicited similar RPE responses for all three trials, the responses were not steady-
state because RPE increased at the end of the exercise trials.  It is likely that general fatigue 
development over the course of the exercise contributed to the higher RPE values recorded at 
the end of each trial. 
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IL-6
Plasma IL-6 significantly increased from pre-exercise to post-exercise for each of the 
Intensive Training Trials.  The pre-exercise and post-exercise values obtained in the present 
investigation are in accordance with those found in other studies.5, 10, 17, 20, 21, 42 The post-
exercise values obtained in this study; however, were lower than those found in some studies. 
24, 45 The participants in both the Ostrowski et al.24 study and the Ullum et al.45 study were of 
a similar age and fitness status of those utilized in the present study, so the differences in IL-
6 increase are likely due to other factors. One possible factor is that the protocol utilized by 
Ostrowski et al.24 involved completion of the Copenhagen marathon (42.2 km).  This type of 
competitive exercise involves running at an intensity that is not necessarily steady-state for 
several hours continuously.  It has been noted that IL-6 release is dependent on both exercise 
intensity and duration.14, 28, 37, 40 It may be that the degree of muscle damage and glycogen 
depletion that occurred during exercise that is several hours in duration would be greater than 
that observed during the 60 minutes of exercise utilized in the present investigation.  
Research has shown that muscle damage elicits a repair process, including the entry of 
macrophages and neutrophils into the cell, which causes an increase in IL-6 production, thus 
greater muscle damage could result in increased IL-6 concentrations.14, 17, 25, 37 This is 
supported by the results of Rogers et al.31 who found the CK response to a marathon to be 
~10 times greater than that presently observed. 
It has also been demonstrated that IL-6 acts directly on liver cells to increase glucose 
release during prolonged exercise if prior carbohydrate ingestion is inadequate.8, 26, 28, 40, 41 In 
a situation such as a marathon, the IL-6 produced in both the muscle cells and the liver acts 
on the liver cells in order to increase glucose output to support the demands of the exercise.8, 
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26, 28, 40, 41  These examples could explain the considerably larger increase in IL-6 found in the 
Ostrowski et al. study.24 
In the case of the study by Ullum et al.45, the participants completed 60 minutes of 
cycling exercise at 75% of VO2max, which is a comparable to the present investigation.  The 
substantially greater post-exercise increase in IL-6 may be due, in some part, to differences in 
assay technology, as the Ullum et al.45 study was conducted approximately 13 years ago.17, 25 
Early cytokine assays exhibited greater levels of cross-reactivity between the various 
cytokines due to lack of monoclonal antibody specificity.  Interestingly; though, the 
magnitude of change post-exercise between the studies was similar (~1.6 fold vs.1.8 fold). 
Percent change in IL-6 was not of a greater magnitude with each successive Intensive 
Training Trial.  It was thought that the percent change for Session II would be of a greater 
magnitude than Session I, and that the percent change for Session III would be of a greater 
magnitude than Session II, indicating an accumulation of this cytokine in the plasma over the 
course of the Intensive Training Trials.  This was not observed in the present investigation. 
Despite the lack of statistically significant findings regarding percent change in IL-6, the 
percent change values observed are supported by other research literature.  Suzuki et al.42 had 
participants complete a comparable protocol to the one utilized in the present investigation.  
Percent change calculated from their data suggests that the percent change in IL-6 from pre- 
to post-exercise are very similar to those obtained in the present investigation (Session I = 
74% vs. 80%).  
 It is unclear why there was a lack of significant findings regarding percent change 
over the course of the Intensive Training Trials.  Perhaps this was due to the fact that the 
participants were given a carbohydrate supplement throughout the study, monitored for 
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caloric intake, and were trained enough that 24 hours of recovery was adequate time to 
recover and clear the IL-6 produced during the exercise.  Obviously, if full recovery is 
achieved and the IL-6 cleared from the blood, there is no possibility for accumulation of the 
cytokine across trials.  
Finally, the baseline concentrations of IL-6 were not significantly elevated following 
each successive Intensive Training Trial, and the following rest day.  Several studies have 
shown that IL-6 increases in response to exercise of various intensities and durations; 
however, it then decreases to baseline values after 24 hours post-exercise.5, 10, 17, 20, 21, 45  In the 
context of this study, 24 hours post-exercise from Session I corresponds to the pre-exercise 
(baseline) of Session II, and so on.  That being said, the results of the aforementioned studies 
support the non-significant baseline results of this investigation.  It appears that within the 
context of the current design, 24 hours is adequate recovery between exercise trials. 
TNF-7
Upon initial analysis, there were no significant increases in TNF-7 from pre-exercise 
to post-exercise for each bout of intensive prolonged exercise.  However, there is some 
disagreement between the TNF-7 values measured in this experiment and TNF-7 reported in 
the research literature.  While the values obtained in the present investigation agree with the 
findings of Dufaux and Order.7 and Suzuki et al.42, they are remarkably higher (4-10X) than 
those found in several other studies.5, 17, 24, 45 
It was noted; however, that the TNF-7 data for one participant was considerably out 
of the range of values found in these studies noted above.  Thorough scrutiny of the data for 
this participant led the investigators to conclude that the participant may have simply been a 
very high responder, as a resting blood sample taken from this participant several weeks after 
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completion of the protocol also showed TNF-7 values that were significantly out of the 
typical range.  Initially, a log transformation of the TNF-7 was performed in order to 
decrease the variability in the data set (n = 7).  After analyzing the standard data values, the 
subject was finally deemed an outlier 19, and removed from the data set for TNF-7. Once 
removed from the data set, the mean values for TNF-7 were much more representative of the 
values found in the above noted studies.   
There were significant increases in TNF-7 after both the log transformation of the 
data was performed, and after the outlier subject data were removed from the analysis.  Both 
of theses analyses showed a significant increase in TNF-7 for Sessions II and III pre- to post-
exercise.  It was thought that TNF-7 would increase from pre-exercise for all three Intensive 
Training Trials; however, this was not the case.  Interestingly, the data obtained in this 
experiment indicated that some of the highest CK values were measured after Sessions II and 
III, which suggests that a greater amount of muscle damage existed during these two sessions 
than in Session I.  As discussed earlier, this muscle damage and resulting tissue inflammation 
elicits a repair process, thus greater muscle damage, as evidenced by higher CK values, 
which may promote increased plasma TNF-7.25, 37 It has been demonstrated that CK shows a 
delayed response in most individuals, peaking anywhere from 24 to 96 hours post-exercise.2, 
23, 35 While the CK values obtained in this study show that the highest values were obtained 
after Session II and Session III, it is a possibility that the increases seen after these sessions 
are the result of CK accumulation from Session I.  
In addition, the percent change in TNF-7 with exercise was not of a greater 
magnitude with each successive Intensive Training Trial as had been hypothesized.  The 
greatest percent change in TNF-7 was achieved during Session II, which, as mentioned, was 
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perceived as the most difficult day for all participants in this study.  Despite the fact that VO2
was steady-state and lactate increased in a similar fashion in the Intensive Training Trials, 
HR results for Session II indicated that HR at several points, including the end of exercise 
(60 minutes), was greater than the same time point in Session III, which suggests that Session 
II was more stressful than Session III. The CK data also showed that the highest CK values 
were measured during Session II. Taken together, these points suggest that Session II was the 
most stressful of the Intensive Training Trials, which could explain the greater percent 
change in TNF-7 for Session II than for Sessions I and III.37 Once again, it must be noted that 
CK shows a delayed response, and the increase in CK during Session II may be the result of 
CK accumulation in the blood.2, 23, 33  Muscle damage likely occurred during Session I, as 
evidenced by increased post-exercise CK. The CK then began to accumulate in the blood, as 
more muscle damage was caused during Session II. The increasing amount of muscle 
damage likely induced a local inflammatory response which caused an upregulation in TNF-
7, as evidenced by the increase in the percent change for Session II.  Due to the fact that the 
inflammation was not due to an invading pathogen, TNF-7 began to be cleared, as evidenced 
by the lack of significant percent change for Session III, while CK continued to increase. 
Finally, the resting concentrations of plasma TNF-7 were not significantly elevated 
on each successive day of intensive prolonged exercise and the final rest day.  It was 
suspected that baseline values of TNF-7 would increase each day, and that the highest 
baseline value of TNF-7 would be found for Session IV.  The highest baseline value of TNF-
7 was, in fact, found for Session IV; however, baseline concentrations did not increase over 
the course of Sessions I, II and III, as was originally thought.  Baseline TNF-7 significantly 
increased only from Session II to Session IV.   
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Some of the existing research literature indicates that exercise has no effect on 
baseline values of TNF-7.7, 24, 42 These studies showed that TNF-7 concentrations were not 
significantly elevated over the pre-exercise baseline values when taken one to three and a 
half hours post-exercise.6, 22, 38 Post-exercise recovery blood samples were not taken in the 
present experiment, so it is not possible to know if TNF-7 returned to baseline in this one to 
three and a half hour time period, but we know that it happened 24 hours post-exercise.  
In contrast, other studies demonstrate that TNF-7 remained elevated 24 hours after 
exercise, and in some cases 72 hours after the initial pre-exercise value.5, 17 This was not 
found in the present experiment.  The differences in baseline TNF-7 between the studies 
could be due to several factors.  Brenner et al.5 utilized a protocol that involved moderately 
trained athletes completing two hours of exercise at 60% of VO2max. As noted earlier, 
cytokine production and release is directly related to exercise intensity and duration.14, 28, 40 
The fact that the Brenner et al.5 exercise protocol was twice the length of the present protocol 
could account for the elevated TNF-7 found 72 hours post-exercise.  The elevated baseline 
TNF-7 for several days after the completion of exercise could also be due to the fact that the 
athletes that completed these two hours of exercise were not as fit as those who participated 
in the present investigation.46 Viru and Viru 46 have noted that with many hormones, an 
increase in the blood occurs if the activity is above a certain threshold; however, with 
exercise training, this threshold increases.  This means that at an identical absolute intensity, 
the trained athlete will have a lower response, or the response will disappear entirely.  These 
trained athletes may release more TNF-7, but they are better at clearing it than the 
moderately trained athlete.  The same principles can be applied to the Moldoveanu et al.17 
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study, which found that TNF-7 was still elevated 24 hours post-exercise, as healthy, but 
untrained men completed three hours of exercise in their investigation. 
IL-6: TNF-7 ratio
Results showed a significant main effect of time for the IL-6:TNF-7 ratio, indicating 
that the ratio increased from pre-exercise to post-exercise during the Intensive Training 
Trials.  Timmons suggests that the IL-6:TNF-7 ratio could be a useful tool in order to look at 
the inflammatory environment of an individual in response to exercise.43 That is, the ratio 
could be used to decipher if exercising is putting the individual in a position that would make 
them more susceptible to infection. An increase in the ratio indicates a greater predominance 
of IL-6, which would suggest a more anti-inflammatory environment.  In contrast, a decrease 
in the ratio, due to TNF- 7 predominance, would suggest a more pro-inflammatory 
environment.  Our IL-6:TNF-7 ratio data suggest that exercise is not making these particular 
athletes more susceptible to infection. It is clear that the ratios increase slightly with exercise, 
due to the increase in circulating IL-6.  The increase in ratio is not detrimental, as it suggests 
that that the environment at the time of exercise was one that was essentially anti-
inflammatory.  In addition, since both cytokines, IL-6 and TNF- 7, appeared to be cleared 
within 24 hours post-exercise there was a lack of an additive effect.  It may be, though, that 
three days of intensive prolonged exercise is the upper limit, as the baseline value of TNF-7
was higher than all other baselines for Session IV.  It is possible that intensive prolonged 
exercise for a fourth day may cause an even greater increase in TNF-7, which would result in 
a lower IL-6:TNF-7 ratio. This lowering of the ratio would indicate a greater pro-
inflammatory environment, which could mean that the athlete is more susceptible to 
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infection.  However, this was not examined in the present investigation, and is speculative, 
thus further research is warranted on this matter.  
Conclusion
In conclusion, three consecutive days on intensive training does not appear to 
increase an athletes susceptibility to infectious illnesses as previously reported in the research 
literature.10, 12, 29, 30, 32, 35, 39, 44, 47  It was originally suggested that the increase in susceptibility 
to infection was associated with OTS, in which frequent, intense training caused a decrease 
in performance, rather than an increase in performance.30, 35, 36 Researchers have suggested a 
cytokine Open Window that occurs in the time period between three and 72 hours after 
exercise, in which an increase in pro-inflammatory cytokines begin the inflammatory 
process.  During this time period, pathogens may gain a “foothold” in the body, because the 
immune system cannot adequately respond to both the inflammation caused by the intensive 
exercise and the pathogen, thus increasing the risk of infection.22, 35 The data from the present 
investigation involving three consecutive days of cycling exercise at 75% of VO2peak suggest 
that while IL-6 concentration in the blood is generally increased with exercise (this response 
was mirrored by TNF-7, but only over the last two days of exercise), it stayed elevated for 
less than 24 hours and does not appear to have an additive effect, indicating a clearance of 
the cytokine. 
CHAPTER VI 
Summary, Conclusions and Recommendations 
Summary
Athletes engaged in intensive exercise have demonstrated an increased susceptibility 
to infectious illnesses.10, 12, 30, 32, 35, 39, 44, 47 Pro-inflammatory cytokines are released into the 
circulatory system in response to intensive exercise, causing inflammation.24 The immune 
system is then occupied with the task of responding to that inflammation for up to several 
days following the exercise.18 The cytokine Open Window model, in which several 
consecutive days of intensive training decrease function of the immune system, has been 
suggested to explain this increased susceptibility to illness that occurs in the time period 
between three and 72 hours after exercise.22, 35 
The purposes of this experiment were to determine the acute and cumulative 
responses of IL-6 and TNF-7 to the three days of intensive training, and to determine if there 
were differences in baseline values of IL-6 and TNF-7 during three days of intensive 
training.  Seven highly trained males (Mean ± SD: age = 29.1 ± 7.0 yr, height = 180.7 ± 7.4 
cm, mass = 78.8 ± 4.7 kg, body fat % = 13.8 ± 2.6, VO2peak = 59.7 ± 7.7 ml/kg/min-1)
completed three Intensive Training Trials (Sessions I-III) which consisted of 60 minutes of 
cycling at ~75%VO2peak. Resting, baseline and post-exercise blood samples were taken to 
determine IL-6 and TNF-7 concentrations for Sessions I-III.  Session IV consisted of only a 
resting, baseline blood sample. 
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Results indicated a significant main effect of exercise for IL-6 (p = 0.002). Mean pre-
exercise IL-6 was 4.43 ± 2.67 pg/mL and mean post-exercise IL-6 was 8.23 ± 3.67 pg/mL; an 
increase of 85.78%.  There were no significant differences in the percent change or baseline 
IL-6 over the course of the Intensive Training Trials (p > 0.05).  Results also indicated a 
significant session X time interaction (n = 6, p = 0.001) for TNF-7. Analyses revealed a 
significant increase in mean TNF-7 from pre- to post-exercise for both Sessions II and III.  
Results also showed a significantly higher percent change in TNF-7 for Session II than for 
both Session I and Session III, as well as a significantly higher baseline concentration of 
TNF-7 for Session IV than for Session II. Finally, there was a significant main effect for the 
ratio of IL-6:TNF-7. The mean pre-exercise IL-6:TNF-7 was 24.69 ± 15.47. Post-exercise, 
this ratio increased 60.76% to 39.69 ± 16.36, suggesting the existence of anti-inflammatory 
environment. 
These results indicate that three days of Intensive Training Trials consisting of 60 
minutes of cycling exercise at ~75% of VO2peak do not result in a significant widening of the 
Open Window period, meaning that athletes who train intensively for three consecutive days 
do not appear to be at a greater risk of becoming ill or developing the OTS.  It is clear that 
IL-6 increases with exercise (TNF- 7 partially); however, it stays elevated for only a short 
period of time, as evidenced by both the clearance of this cytokine within 24 hours post-
exercise and the lack of an additive effect.   
Conclusions
Hypothesis 1: Plasma IL-6 will be significantly increased from rest immediately post-
exercise for each bout of intensive training. This hypothesis was accepted. IL-6 was 
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significantly increased from pre-exercise to post-exercise for all three of the Intensive 
Training Trials. 
Hypothesis 2: The percent change in IL-6 will be of a greater magnitude with each successive 
bout of intensive training. This hypothesis was rejected. The percent change in IL-6 did not 
change over the course of the three Intensive Training Trials. 
Hypothesis 3: The resting, baseline concentrations of plasma IL-6 will be significantly 
elevated following each successive day of intensive training, and the following rest day.  This 
hypothesis was rejected. There were no significant increases in resting, baseline IL-6. This 
baseline remained stable throughout the duration of the three days of Intensive Training 
Trials. 
Hypothesis 4: Plasma TNF-7 will be significantly increased from rest immediately post- 
exercise for each bout of intensive training.  This hypothesis was rejected. TNF-7 was 
significantly elevated immediately post-exercise for Sessions II and Session III, but not for 
Session I. 
Hypothesis 5: The percent change in TNF-7 will be of a greater magnitude with each 
successive bout of intensive training. This hypothesis was rejected. The percent change 
obtained for Session II was of a significantly greater magnitude than both Sessions I and III.   
Hypothesis 6: The resting, baseline concentrations of plasma TNF-7 will be significantly 
elevated for each successive day of intensive training, and the following rest day.  This 
hypothesis was rejected. Resting, baseline TNF-7 was expected to significantly increase with 
each successive training trial; however, it was only significantly higher for Session IV than 
for Session II.  
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Recommendations for Future Research
In order to gain more insight into the cytokine response to several of intensive training, the 
investigator recommends that future researchers: 
• Repeat the experiment with an increased number of participants 
• Repeat the experiment with a fourth Intensive Training Trial  
• Repeat the experiment using a different mode of exercise, such as running 
• Repeat the experiment using different intensities and durations of exercise 
• Repeat the experiment with sedentary individuals, as well as moderately trained athletes  
• Repeat the experiment and include other cytokines in addition to IL-6 and TNF-7
• Continue to take blood samples for several hours into recovery 
• Have participants complete two exercise sessions within one day 
• Strictly control the caloric intake of the participants in the study, instead of asking them 
to follow general guidelines and consume a carbohydrate supplement 
• Control VO2 more tightly during exercise 
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APPENDIX A: 
Medical Screening Forms 
 
* These materials are not included in the copyright of Melissa B. Behr 
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APPENDIX B: 
Physical Screening Forms 
* These materials are not included in the copyright of Melissa B. Behr 
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APPENDIX C: 
 
Data Collection Forms 
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Subject______                               Orientation Session 
Date______ 
 
Informed Consent  
1. Inform participant of the experimental protocol  
2. Make participant aware of the possible risks 
3. Sign informed consent 
 
Participant Compliance Questions 
1. Did the participant perform strenuous physical activity for 24 hours prior to VO2peak testing:  
Y N
2. Did the participant eat, smoke or consume alcohol or caffeine 2 hours prior to testing:    
Y N
Examinations _______ 
1. Medical Examination  
2. 12 Lead EKG 
3. Physical Examination  
 
Physical Characteristics 
1. Sex _______ 
2. Age _______ yrs 
3. Height _______ cm 
4. Weight _______ kg 
5. Percent Body Fat _______%; Skinfolds: 
a. Chest ______mm ______ mm ______ mm; Mean = ______mm 
b. Ilium ______mm ______mm ______mm; Mean = ______mm 
c. Abdomen ______mm ______mm ______mm; Mean = ______mm 
d. Axilla ______mm ______ mm ______ mm; Mean = ______mm 
e. Sum of Skinfolds ______mm 
 
Before VO2peak Protocol 
1. Set up metabolic system (calibrate, mouthpiece, etc)  
2. Fit cycle ergometer to the participant  - record seat position using flexible tape (line tape up 
from black cross bar on back of seat to the clear piece of tape on the cycle)  
Seat height: _______ cm 
3. Fit polar heart rate (HR) monitor to participant 
4. Make sure polar heart rate monitor picks up signal  
5. Place RPE scale near cycle ergometer/explain RPE to participant  
 
Warm Up 
1. 5 minutes of cycling at 50W  
2. 5 minutes of stretching focused on the lower body  
3. Record resting oxygen consumption for 4 minutes (have participant sit on bike) – headpiece 
(NOT mouthpiece) is mandatory for all MAX tests  
 
VO2peak Protocol 
1. Stage 1: 50W for 3 minutes HR _________; RPE _________ 
2. Stage 2: 100W for 3 minutes HR _________; RPE _________ 
3. Stage 3: 150W for 3 minutes HR _________; RPE _________ 
4. Stage 4: 200W for 3 minutes HR _________; RPE _________ 
5. Stage 5: 225W for 1 minute HR _________; RPE _________ 
6. Stage 6: 250W for 1 minute HR _________; RPE _________ 
7. Stage 7: 275W for 1 minute HR _________; RPE _________ 
8. Stage 8: 300W for 1 minute HR _________; RPE _________ 
9. Stage 9: 325W for 1 minute HR _________; RPE _________ 
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10. Stage 10: 350W for 1 minute HR _________; RPE _________ 
11. Stage 11: 375W for 1 minute HR _________; RPE _________ 
12. Stage 12: 400W for 1 minute HR _________; RPE _________ 
13. Increase workload until volitional fatigue  add more stages if necessary (record to right) 
14. Recovery - reduce resistance and have participant continue pedaling 
15. Participant rests (supine) until HR is less than or equal to 100 bpm 
 
Prior to Participant Exiting – Give canister of polycose supplement. Instruct the participant as 
follows:  
1. Consume 25% of the canister throughout the day before Session II 
2. Consume 25% of the canister throughout the day of Session II 
3. Consume 25% of the canister throughout the day of Session III 
4. Consume 25% of the canister throughout the day of Session IV 
5. Instruct the participant to bring the empty canister with them for Session V 
6. Instruct the participant to write down everything they eat and drink on the day preceding 
Session II, as well as on the days of Session II, III and IV 
 
Criteria for valid VO2peak Test  
1. Did the participant have a maximal RER equal to or greater than 1.1? RER = _________ 
2. Did the participant reach age predicted maximal HR (220-age ± 5%)? HRmax = _________ 
3. Did the participant have a RPE equal to or greater than 18? RPE = _________ 
4. Was the total test time equal to or greater than 12 minutes? Test time = _________ 
 
Power Output Estimation for Intensive Training Trials 
1. VO2peak = _________ 
2. Peak Workload = __________ 
3. Workload that corresponds to 75% VO2peak  = _________ 
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Subject_____                 SESSION    I     II     III 
Date_____               (circle one) 
Time_____ 
 
Special Notes 
1. Session I must start at least one week after determination of VO2peak 
2. Sessions I-III must be spaced 24 hours apart, at or about the same time each day 
 
Participant Compliance Questions (some only apply to Session II) 
1. Did the participant perform an easy day of training 2 days prior to the start of session I?Y N N/A 
2. Did the participant perform activity the day prior to Session I?  Y   N   N/A 
3. Did the participant consume 25% of the polycose supplement the day prior to the Session? Y N    
4. Has the participant been sick in the 6 week period prior to testing?  Y   N   N/A 
5. Did the participant eat, smoke or consume alcohol or caffeine 8 hours prior to testing?  Y   N 
6. Has the participant taken any NSAIDS in the past 24 hours?  Y   N 
 
Before Starting Exercise Protocols for Sessions II-IV 
1. Collect the Food Diary from the participant 
2. Set up metabolic system (calibrate, mouthpiece, etc) NOTE: use only the mouthpiece for the 
submaximal exercise sessions.  
3. Set up blood supplies 
4. Set up cycle ergometer to previously recorded seat height: ________ cm 
5. Fit polar heart rate (HR) monitor to participant 
6. Make sure polar heart rate monitor picks up signal 
7. Place RPE scale near cycle ergometer 
 
Exercise Protocol for Sessions II-IV 
1. The participant will rest in the supine position for 10 minutes  
2. Obtain 3-mL of venous blood using the standard Venipuncture technique 
3. Placed blood into a sterile K2 - EDTA (purple top) Vacutainer® tube  
4. Place tube on ice immediately 
5. 10 minute warm up  
a. 5 minutes of cycling at 50W  
b. 5 minutes of stretching focused on the lower body 
6. Record resting oxygen consumption for 4 minutes with participant seated on bike (remove 
mouthpiece after sampling) 
7. Cycle for 60 minutes at the previously determined workload that elicits 75% of VO2peak 
a. Min 0  HR _________; RPE _________ 
b. Minute 10  HR _________; RPE _________ 
c. Minutes 16-20  VO2 measurement (remove mouthpiece after sampling) 
d. Minute 20  HR _________; RPE _________ 
e. Minute 30  HR _________; RPE _________ 
f. Minutes 36-40  VO2 measurement (remove mouthpiece after sampling) 
g. Minute 40  HR _________; RPE _________ 
h. Minute 50  HR _________; RPE _________ 
i. Minutes 56-60  VO2 measurement (remove mouthpiece after sampling) 
j. Minute 60  HR _________; RPE _________ 
8. Recovery - assist participant off bike, and have them rest (supine) 
9. Obtain 3-mL of venous blood using the standard Venipuncture technique 
10. Placed blood into a sterile K2 - EDTA (purple top) Vacutainer® tube  
11. Place tube on ice immediately 
12. Participant rests (supine) until HR is less than or equal to 100 bpm 
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Subject_____                    SESSION IV 
Date_____ 
Time_____ 
 
Special Notes 
• Sessions IV must occur ~24 hours after session IV 
 
Participant Compliance Questions 
1. Did the participant eat, smoke or consume alcohol or caffeine 8 hours prior to testing?  Y   N  
2. Has the participant taken any NSAIDS in the past 24 hours?  Y   N 
3. Did the participant consume 25% of the polycose supplement the day prior to the Session? Y N    
 
Before Starting Protocols for Sessions V 
1. Collect the Food Diary from the participant 
2. Set up blood supplies 
 
Session V Protocol 
1. No exercise will be performed on this day   
2. The participant will rest in the supine position for 10 minutes  
3. Obtain 3-mL of venous blood using the standard Venipuncture technique 
4. Placed blood into a sterile K2 - EDTA (purple top) Vacutainer® tube  
5. Place tube on ice immediately 
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APPENDIX D: 
Assay Information 
 
* These materials are not included in the copyright of Melissa B. Behr 
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IL-6 Assay 
71 
TNF-7 Assay 
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